Rimac Hrvoje, Debeljak Željko, Bojić Mirza, Miller Larisa
Department of Medicinal Chemistry, Faculty of Pharmacy and Biochemistry, University of Zagreb, Zagreb. Croatia.
Institute of Clinical Laboratory Diagnostics, Osijek University Hospital, 31000 Osijek. Croatia.
Curr Med Chem. 2017;24(18):1930-1947. doi: 10.2174/0929867324666170202152134.
Human serum albumin (HSA) is the most abundant protein in human serum. It has numerous functions, one of which is transport of small hydrophobic molecules, including drugs, toxins, nutrients, hormones and metabolites. HSA has the ability to interact with a wide variety of structurally different compounds. This promiscuous, nonspecific affinity can lead to sudden changes in concentrations caused by displacement, when two or more compounds compete for binding to the same molecular site.
It is important to consider drug combinations and their binding to HSA when defining dosing regimens, as this can directly influence drug's free, active concentration in blood.
In present paper we review drug interactions with potential for displacement from HSA, situations in which they are likely to occur and their clinical significance. We also offer guidelines in designing drugs with decreased binding to HSA.
人血清白蛋白(HSA)是人体血清中含量最丰富的蛋白质。它具有多种功能,其中之一是运输小的疏水分子,包括药物、毒素、营养物质、激素和代谢产物。HSA能够与多种结构不同的化合物相互作用。当两种或更多种化合物竞争结合到同一分子位点时,这种杂乱的、非特异性的亲和力可能导致因置换而引起的浓度突然变化。
在确定给药方案时考虑药物组合及其与HSA的结合很重要,因为这会直接影响药物在血液中的游离活性浓度。
在本文中,我们综述了有可能从HSA上被置换的药物相互作用、它们可能发生的情况及其临床意义。我们还提供了设计与HSA结合减少的药物的指导原则。